Intravenous ravulizumab in mechanically ventilated patients hospitalised with severe COVID-19: a phase 3, multicentre, open-label, randomised controlled trial.

D, Annane; SJ, Pittock; HS, Kulkarni; BW, Pickering; MR, Khoshnevis; JL, Siegel; CA, Powell; P, Castro; T, Fujii; D, Dunn

doi:10.1016/s2213-2600(23)00082-6

Intravenous ravulizumab in mechanically ventilated patients hospitalised with severe COVID-19: a phase 3, multicentre, open-label, randomised controlled trial.

NobleIDNI4P74W88R49S74

Type:Journal Article

0 views

Support unavailableClaim Your Authorship

Embeddable Badge

[![NobleID](https://www.nobleid.org/api/badge/AEBC9DA5.svg?ark=w1%2F20260526%2FAEBC9DA5&value=id)](https://nobleid.org/work/w1/20260526/AEBC9DA5)

ARK Inflections

Metadata (JSON)Policy

Metadata Formats

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors

Claim authorship of this work

Intravenous ravulizumab in mechanically ventilated patients hospitalised with severe COVID-19: a phase 3, multicentre, open-label, randomised controlled trial.

NobleIDNI4P74W88R49S74

Type:Journal Article

0 views

Support unavailableClaim Your Authorship

Embeddable Badge

[![NobleID](https://www.nobleid.org/api/badge/AEBC9DA5.svg?ark=w1%2F20260526%2FAEBC9DA5&value=id)](https://nobleid.org/work/w1/20260526/AEBC9DA5)

ARK Inflections

Metadata (JSON)Policy

Metadata Formats

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors

Claim authorship of this work